Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

Breakthrough Breast Cancer's Comment On New Targeted Antibody Therapy For Advanced Her2-Positive Breast Cancer
Dr Alexis Willett, Head of Policy & Involvement at Breakthrough Breast Cancer, says:
generic viagra online
Breast Cancer Risk In Postmenopausal Women Exposed To Hormone Replacement Therapy, Could Be Reduced By Asian Spice
Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.
News of the day
Ilaris® Recommended For European Approval As New Biologic Drug To Treat A Rare But Serious Group Of Auto-inflammatory Diseases
The biotechnology medicine Ilaris® (canakinumab) has passed another major milestone with a recommendation for approval in the European Union to treat patients with a life-long and potentially fatal auto-inflammatory disease called cryopyrin-associated periodic syndrome (CAPS). When approved, Ilaris will be the only treatment in the EU indicated for CAPS patients aged four years and older[1].
Endocrinology

To Lead The Transformation Of Health Care, Young Physicians Selected For Prestigious National Fellowship

The Robert Wood Johnson Foundation Clinical Scholars Program® is pleased to announce the selection of 29 young physicians who will learn to conduct innovative research and work with communities, organizations, practitioners and policy-makers on issues important to the health and well-being of all Americans. They will begin their prestigious two-year fellowships in July 2010. "Clinical Scholars are leading change through every level of the health care system including community practice, local and state government, the federal government, and professional organizations," said Desmond K. Runyan, M.D., Dr.P.H., national program director for the Clinical Scholars Program. The new Clinical Scholars are outstanding young physicians who were selected competitively from applicants enrolled in medical and surgical residencies across the United States. Scholars conduct research in diverse, health-related fields such as health care delivery and financing, clinical decision-making, biomedical ethics, and health care policy. The program also includes leadership training and engagement in community-based, participatory research. Clinical Scholars receive their training at one of four universities: Yale University, the University of Pennsylvania, the University of Michigan, or the University of California, Los Angeles. Through the program scholars will spend two years examining the delivery, impact and organization of health care. This background will help prepare them to lead efforts to transform health care in this country through positions in academic medicine, public health and other leadership roles. They join a distinguished group of over 1,100 alumni who include prominent leaders of public and private agencies at the state and national levels, five public health and medical school deans, 40 Institute of Medicine members, 19 medical school department chairs, over 100 vice chairs of departments or division chiefs, and numerous medical school professors. This training program, established in 1969 and supported by the Robert Wood Johnson Foundation since 1972, is one of the oldest and most prestigious fellowships awarded to physicians. The Department of Veterans Affairs will be a partner supporting nine of the 29 Scholars. Desmond Runyan, M.D., Dr.P.H. IQ Solutions, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009